NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.940
+0.050 (5.62%)
At close: Nov 6, 2024, 4:00 PM
0.960
+0.020 (2.13%)
Pre-market: Nov 7, 2024, 7:19 AM EST
NMTC Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 6, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Market Capitalization | 29 | 21 | 27 | 47 | 29 | 25 | |
| Market Cap Growth | 5.69% | -22.25% | -42.21% | 66.31% | 12.95% | -41.02% | |
| Enterprise Value | 28 | 18 | 17 | 39 | 32 | 24 | |
| Last Close Price | 0.94 | 0.89 | 1.69 | 3.95 | 3.85 | 5.61 | |
| PE Ratio | - | -1.36 | -2.70 | -4.25 | -1.53 | -3.27 | |
| PS Ratio | 5.96 | 6.25 | 12.92 | 195.10 | 14.79 | - | |
| PB Ratio | 8.69 | 3.41 | 2.85 | 7.23 | 13.79 | -20.39 | |
| P/FCF Ratio | -1.96 | -1.60 | -3.51 | -5.47 | -8.03 | -4.63 | |
| P/OCF Ratio | -1.98 | -1.65 | -3.64 | -5.51 | -8.32 | -4.68 | |
| EV/Sales Ratio | 7.04 | 5.41 | 8.23 | 159.21 | 16.47 | - | |
| EV/EBITDA Ratio | -1.66 | -1.57 | -1.76 | -3.82 | -6.54 | -4.15 | |
| EV/EBIT Ratio | -1.63 | -1.54 | -1.74 | -3.79 | -6.47 | -4.13 | |
| EV/FCF Ratio | -1.75 | -1.39 | -2.24 | -4.46 | -8.94 | -4.40 | |
| Debt / Equity Ratio | 0.10 | 0.03 | 0.02 | 0.05 | 0.68 | - | |
| Debt / FCF Ratio | -0.03 | -0.01 | -0.03 | -0.04 | -0.40 | - | |
| Asset Turnover | 0.74 | 0.33 | 0.20 | 0.04 | 0.73 | - | |
| Inventory Turnover | 5.15 | 6.94 | 12.88 | - | - | - | |
| Quick Ratio | 1.20 | 2.97 | 3.61 | 5.88 | 1.71 | 0.15 | |
| Current Ratio | 2.42 | 4.08 | 3.93 | 6.17 | 1.76 | 0.17 | |
| Return on Equity (ROE) | -349.13% | -149.61% | -123.77% | -230.81% | -3292.36% | - | |
| Return on Assets (ROA) | -143.33% | -71.43% | -60.39% | -100.59% | -115.79% | -967.18% | |
| Return on Capital (ROIC) | -205.63% | -92.01% | -75.18% | -123.55% | -274.63% | - | |
| Earnings Yield | -41.79% | -55.68% | -36.50% | -20.99% | -47.86% | -26.87% | |
| FCF Yield | -39.32% | -62.31% | -28.45% | -18.29% | -12.45% | -21.62% | |
| Buyback Yield / Dilution | -49.78% | -13.27% | -49.56% | -97.52% | -37.01% | -43.18% | |
| Total Shareholder Return | -49.78% | -13.27% | -49.56% | -97.52% | -37.01% | -43.18% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.